Trail Ridge Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Sell
1,375
-36
-3% -$36.8K 0.7% 36
2026
Q1
$1.3M Buy
1,411
+22
+2% +$22.3K 0.56% 44
2025
Q4
$1.49M Buy
1,389
+14
+1% +$13.4K 0.64% 39
2025
Q3
$1.05M Buy
1,375
+10
+0.7% +$7.44K 0.47% 48
2025
Q2
$1.01M Sell
1,365
-32
-2% -$24.9K 0.49% 47
2025
Q1
$1.15M Sell
1,397
-234
-14% -$195K 0.59% 41
2024
Q4
$1.26M Buy
1,631
+18
+1% +$14.9K 0.6% 43
2024
Q3
$1.46M Buy
1,613
+6
+0.4% +$5.39K 0.69% 43
2024
Q2
$1.45M Buy
1,607
+3
+0.2% +$2.4K 0.75% 39
2024
Q1
$1.25M Buy
1,604
+1,073
+202% +$764K 0.71% 40
2023
Q4
$310K Buy
+531
New +$310K 0.19% 87
2023
Q1
Sell
-721
Closed -$264K 123
2022
Q4
$264K Sell
721
-30
-4% -$10.6K 0.18% 105
2022
Q3
$265K Hold
751
0.18% 114
2022
Q2
$243K Hold
751
0.16% 135
2022
Q1
$215K Sell
751
-92
-11% -$23.7K 0.13% 131
2021
Q4
$233K Buy
+843
New +$214K 0.14% 126

Other funds holding LLY

Trail Ridge Investment Advisors's LLY Position: Q2 2026 in Review

Trail Ridge Investment Advisors reduced its Eli Lilly (LLY) stake by 2.6% in Q2 2026, selling an estimated $36.8K and leaving 1,375 shares worth $1.65M. The position accounts for 0.7% of the portfolio, ranked #36.

Trail Ridge Investment Advisors first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Trail Ridge Investment Advisors held 1,375 shares of Eli Lilly worth $1.65M as of Q2 2026.
  • Trail Ridge Investment Advisors sold 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
  • Eli Lilly made up 0.7% of Trail Ridge Investment Advisors's portfolio in Q2 2026, its #36 holding.
  • Trail Ridge Investment Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Trail Ridge Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.